Low-molecular-weight heparin compared with unfractionated heparin for patients with non–ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE initiative

Author： Singh Kanwar   Roe Matthew   Peterson Eric   Chen Anita   Mahaffey Kenneth   Goodman Shaun   Harrington Robert   Smith Sidney   Gibler W.   Ohman E.   Pollack Charles  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.21, Iss.3, 2006-06, pp. : 211-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa Blockers in Non-ST Elevation Acute Coronary Syndromes: Only for Well Defined Subgroups or a Therapeutic Option for All Patients?

By Verheugt Freek W.A.  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 81-84

Springer Publishing Company

Access to resources Recommend Favorite

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the national registry of myocardial infarction 4

By Peterson E.D.   Pollack C.V.   Roe M.T.   for the National Registry of Myocardial Infarction NRMI 4 Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

By Akkerhuis K.M.  

European Heart Journal, Vol. 21, Iss. 5, 2000-03 ,pp. : 371-381

Oxford University Press

Access to resources Recommend Favorite

Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation

By Luca Giuseppe   Gibson C.   Gyöngyösi Mariann   Zeymer Uwe   Dudek Dariusz   Arntz Hans-Richard   Bellandi Francesco   Maioli Mauro   Noc Marko   Zorman Simona   Gabriel H.   Emre Ayse   Cutlip Donald   Rakowski Tomasz   Huber Kurt   van’t Hof Arnoud  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 3, 2010-10 ,pp. : 342-346

Springer Publishing Company

Access to resources Recommend Favorite

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

By Saucedo Jorge F.   Lui Henry K.   Garza Luis   Guerra G. Jose   Jacoski Mary V.   Jennings Lisa K.  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 2, 2004-10 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite